Intuitive Surgical, Inc. $ISRG Stock Position Lifted by Canada Post Corp Registered Pension Plan

Canada Post Corp Registered Pension Plan grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 217.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,426 shares of the medical equipment provider’s stock after acquiring an additional 13,994 shares during the quarter. Canada Post Corp Registered Pension Plan’s holdings in Intuitive Surgical were worth $8,972,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Rossmore Private Capital grew its position in shares of Intuitive Surgical by 2.0% during the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after buying an additional 20 shares during the last quarter. Activest Wealth Management boosted its stake in Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after acquiring an additional 20 shares during the period. Vertex Planning Partners LLC boosted its stake in Intuitive Surgical by 2.3% in the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after acquiring an additional 21 shares during the period. Accredited Investors Inc. grew its holdings in shares of Intuitive Surgical by 2.0% during the third quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock valued at $474,000 after purchasing an additional 21 shares during the last quarter. Finally, Evermay Wealth Management LLC raised its position in shares of Intuitive Surgical by 3.1% during the 2nd quarter. Evermay Wealth Management LLC now owns 731 shares of the medical equipment provider’s stock worth $397,000 after purchasing an additional 22 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 126 shares of the company’s stock in a transaction that occurred on Thursday, January 29th. The stock was sold at an average price of $520.02, for a total value of $65,522.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 750 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The SEC filing for this sale provides additional information. Insiders have sold 73,616 shares of company stock valued at $40,929,575 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 2.5%

ISRG stock opened at $488.15 on Friday. The company has a 50-day simple moving average of $549.63 and a 200 day simple moving average of $510.54. The company has a market capitalization of $173.36 billion, a P/E ratio of 61.87, a PEG ratio of 3.70 and a beta of 1.65. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating the consensus estimate of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. During the same quarter last year, the company earned $2.21 EPS. Equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Leerink Partners boosted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Royal Bank Of Canada boosted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, January 21st. Rothschild & Co Redburn lifted their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $714.00 target price on shares of Intuitive Surgical in a research note on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.